Literature DB >> 2365034

Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis.

J Gluskowski1, I Hawrylkiewicz, D Zych, J Zieliński.   

Abstract

Effects of 12 months steroid treatment on pulmonary haemodynamics in 24 patients with pulmonary sarcoidosis, stage II and III, were investigated. All patients had a chest radiograph, lung function tests, and pulmonary haemodynamics (measured at rest and during submaximal exercise) prior to the treatment. Resting pulmonary hypertension was found in 3 patients. In 18 an abnormal increase in pulmonary arterial mean pressure (PAP) on exercise was observed. All investigations were repeated after a year of treatment. In almost all patients (22) a regression of radiological changes in the lungs and improvement of pulmonary function were observed. The changes in pulmonary circulation were less uniform. In only half of the patients studied was regression of the disease seen on chest X-ray and improvement in lung function accompanied by improvement in pulmonary haemodynamics.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2365034

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  Pulmonary hypertension in Hodgkin's disease.

Authors:  Matthew Exline; Cynthia Magro; Thomas Lin; Namita Sood
Journal:  Thorax       Date:  2007-04       Impact factor: 9.139

Review 2.  Right ventricular dysfunction in chronic lung disease.

Authors:  Todd M Kolb; Paul M Hassoun
Journal:  Cardiol Clin       Date:  2012-05       Impact factor: 2.213

3.  Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis.

Authors:  H Nunes; M Humbert; F Capron; M Brauner; O Sitbon; J-P Battesti; G Simonneau; D Valeyre
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

Review 4.  Pulmonary hypertension caused by sarcoidosis.

Authors:  Enrique Diaz-Guzman; Carol Farver; Joseph Parambil; Daniel A Culver
Journal:  Clin Chest Med       Date:  2008-09       Impact factor: 2.878

5.  Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience.

Authors:  Christopher F Barnett; Eric J Bonura; Steven D Nathan; Shahzad Ahmad; Oksana A Shlobin; Kwabena Osei; Ari L Zaiman; Paul M Hassoun; David R Moller; Scott D Barnett; Reda E Girgis
Journal:  Chest       Date:  2008-12-31       Impact factor: 9.410

Review 6.  Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.

Authors:  Mazen Al-Qadi; Barbara LeVarge; H James Ford
Journal:  Front Med (Lausanne)       Date:  2021-03-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.